Vitrolife AB (FRA:VTFN) EPS (Basic): €-3.40 (TTM As of Mar. 2026)


FRA:VTFN Vitrolife AB FRA:VTFN
78 GF Score
Price €7.75
GF Value €14.38
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Vitrolife AB EPS (Basic)?

Vitrolife AB FRA:VTFN -0.83% 78 EPS (Basic) is €-3.40 as of Mar. 2026. GuruFocus rates FRA:VTFN with a GF Score™ of 78/100 and a GF Value™ of €14.38 (Possible Value Trap). The stock has 6 warning signs investors should review.

Vitrolife AB's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was €0.07. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was €-3.40.

Vitrolife AB's EPS (Diluted) for the three months ended in Mar. 2026 was €0.07. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €-3.40.

Vitrolife AB's EPS without NRI for the three months ended in Mar. 2026 was €0.07. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 0.27.

During the past 12 months, Vitrolife AB's average EPS without NRIGrowth Rate was -21.30% per year. During the past 3 years, the average EPS without NRI Growth Rate was -1.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 4.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was 6.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Vitrolife AB's highest 3-Year average EPS without NRI Growth Rate was 92.90% per year. The lowest was -49.60% per year. And the median was 8.80% per year.

Vitrolife AB  (FRA:VTFN) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Vitrolife AB EPS (Basic) Related Terms

Vitrolife AB EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Vitrolife AB's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vitrolife AB EPS (Basic) Chart

Vitrolife AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.29 0.27 -2.54 0.33 -3.40

Vitrolife AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.07 0.07 -3.61 0.07
FRA:VTFN
78GF Score
Vitrolife AB FRA:VTFN
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vitrolife AB EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Vitrolife AB's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-460.564-0)/135.423
=-3.40

Vitrolife AB's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(9.377-0)/135.423
=0.07

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-3.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of €-3.40 mean?
Vitrolife AB (FRA:VTFN) has a EPS (Basic) of €-3.40 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Vitrolife AB and its competitors.
Is Vitrolife AB's EPS (Basic) too high?
Vitrolife AB's current EPS (Basic) is €-3.40. Overall, Vitrolife AB has a GF Score™ of 78/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vitrolife AB's EPS (Basic) compare to ABT and SYK?
Vitrolife AB's EPS (Basic) of €-3.40 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Devices & Instruments company?
A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Vitrolife AB and its competitors. Vitrolife AB's current EPS (Basic) is €-3.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitrolife AB stock overvalued right now?
Based on GuruFocus' analysis, Vitrolife AB (FRA:VTFN) is currently considered Possible Value Trap. The stock's GF Value™ is €14.38, compared to a current price of €7.75 — trading 46.1% below its estimated fair value. The current EPS (Basic) is €-3.40. Vitrolife AB's overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Vitrolife AB (FRA:VTFN), the current EPS (Basic) is €-3.40 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vitrolife AB (FRA:VTFN) Overvalued in 2026?

Based on GuruFocus' analysis, Vitrolife AB stock appears to be undervalued. The current stock price of €7.75 is trading 46.1% below its estimated GF Value™ of €14.38. GuruFocus considers Vitrolife AB to be Possible Value Trap.

Key valuation signals for FRA:VTFN:

  • EPS (Basic): €-3.40
  • GF Value™: €14.38 vs. price of €7.75 (46.1% below fair value)
  • GF Score™: 78/100 with 6 warning signs

No single metric tells the full story. See the FRA:VTFN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vitrolife AB Business Description

Address Box 9080, Gothenburg, SWE, 400 92
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The company has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.
78GF Score

Get the complete analysis for FRA:VTFN

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.75
Price
€14.38
GF Value